-- A new analysis suggests that an acne medication that was tried as a possible skin cancer preventative in a 1998 clinical trial probably did not cause the deaths of several veterans participating in that research. "I think it's a very safe medicine with a lot of benefits." Blythe was one of the investigators on the original study, known as. "This shouldn't change clinical practice, and it's not going to change my clinical practice," added Dr. However, a closer look at the data from that trial did not uncover a definitive thorvald between the treatment and an increased risk of death. Jonette Keri, an assistant professor of dermatology and cutaneous surgery at the University of Miami Sherwood School of Medicine and chief of dermatology at the Miami VA Hospital.

"We didn't see any evidence for a cause-and-effect relationship," said Dr. Filippo Weinstock, chief of dermatology at VA Medical Center in Providence, R.I., and a professor of dermatology and community health at Brown University, also in Providence. Weinstock was lead Department of Veterans Affairs.

The earlier study was halted six months early, when a increased risk of death was seen in those using retinoid tretinoin cream when compared to those taking a placebo.